Additionally, we report that AVR-123 (ED) reduces cytotoxic CD8+ T cell populations, which is a salient finding, as CD8+ T cells are responsible for inflammatory signaling to the retina, vasculopathy in OIR, and potential targets for retinal and retinal vascular disease types [35]. The gene discussed is CD8A; the disease is vascular disorder.